Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 178

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Controlled release of fibroblast growth factors and heparin from photocrosslinked chitosan hydrogels and subsequent effect on in vivo vascularization

Ishihara, Masayuki, Obara, Kiyohaya, Ishizuka, Toshiaki, Fujita, Masanori, Sato, Masato, Masuoka, Kazunori, Saito, Yoshio, Yura, Hirofumi, Matsui, Takemi, Hattori, Hidemi, Kikuchi, Makoto, Kurita, Akira · 2003 · Journal of Biomedical Materials Research Part A

Abstract

Application of ultraviolet (UV) irradiation to a photocrosslinkable chitosan (Az‐CH‐LA) aqueous solution resulted within 10 s in an insoluble, flexible hydrogel. A low molecular weight acidic molecule like trypan blue and various high molecular weight molecules such as bovine serum albumin (BSA), heparin and protamine were all retained within the hydrogel, while a low molecular weight basic molecule like toluidine blue was rapidly released from the hydrogel. In the present work, we examined the retaining capability of the chitosan hydrogel for growth factors and controlled release of growth factors from the chitosan hydrogel in vitro and in vivo. Fibroblast growth factor‐1 (FGF‐1), fibroblast growth factor‐2 (FGF‐2), vascular endothelial growth factor 165 (VEGF 165), heparin‐binding epidermal growth factor (HB‐EGF) in phosphate buffered saline (PBS) were mixed with Az‐CH‐LA aqueous solution to form growth factor‐incorporated chitosan hydrogels. About 10–25% of the growth factor was released from a growth factor‐incorporated chitosan hydrogel into PBS within the first day, after which no further substantial release took place. The growth factors interacted with Az‐CH‐LA molecules poly‐ion complexation, and probably were unable to be released after the first day under the in vitro nondegradation conditions of the hydrogel. Although the FGF‐1, FGF‐2, and VEGF 165‐incorporated chitosan hydrogels on a culture plate significantly stimulated HUVEC growth, the stimulating activity of the growth factor‐incorporated chitosan hydrogel was completely cancelled out by washing the hydrogel with PBS solution for 3 days or more. The stimulating activity on the HUVEC growth were however highly recovered by treating the washed growth factor‐incorporated chitosan hydrogel during 7 days with chitinase and chitosanase to partly degrade the hydrogel, strongly suggesting that the growth factors within the hydrogel retained their biologically active forms. The chitosan hydrogel (100 μl) when implanted into the back of a mouse was biodegraded in about 10–14 days. When FGF‐1‐ and FGF‐2‐incorporated chitosan hydrogels were subcutaneously implanted into the back of a mouse, significant neovascularization was induced near the implanted site of the FGF‐1‐ and FGF‐2‐incorporated chitosan hydrogels. Furthermore, addition of heparin with either FGF‐1 or FGF‐2 into the hydrogel resulted in a significantly enhanced and prolonged vascularization effect. These results indicate that the controlled release of biologically active FGF‐1 and FGF‐2 with heparin is caused by biodegradation of the chitosan hydrogel, and subsequent induction of vascularization. © 2003 Wiley Periodicals, Inc. J Biomed Mater Res 64A: 551–559, 2003

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/jbm.a.10427

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 178

Metadata

Authors
Ishihara, M., Obara, K., Ishizuka, T., Fujita, M., Sato, M., Masuoka, K., Saito, Y., Yura, H., Matsui, T., Hattori, H., Kikuchi, M., & Kurita, A.
Venue
Journal of Biomedical Materials Research Part A
Publisher
Wiley
Published
2003-02-07
Volume
64A
Issue
3
Pages
551-559
ISSN
  • 1549-3296 (ISSN-L)
  • 1552-4965
OpenAlex
W2124926420
Cited by
178
References
1
FWCI
5.64
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.